US equities
|
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Faeth Therapeutics, Inc.
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
September 17, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Tickers
FTH
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
September 08, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Tickers
FTH
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 28, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Tickers
FTH
Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments
August 14, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Tickers
FTH
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 07, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Tickers
FTH
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 23, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Tickers
FTH
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Tickers
FTH
